Skip to content

Brain Connectivity Analysis

Brain Connectivity Analysis to Predict Post Stroke Outcomes Following Traditional and Enhanced Neurorehabilitation by Transcranial Direct Current Stimulation and Anti-inflammatory Biomimetic Nanoparticles

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06823102
Acronym
Neurehab
Enrollment
75
Registered
2025-02-12
Start date
2023-04-28
Completion date
2026-04-27
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neural Injury

Keywords

Non Invasive Brain Stimulation, Inflammation

Brief summary

Stroke remains the leading cause of permanent disability. The neuromodulation technique of transcranial Direct Current Stimulation (tDCS) has the potential to serve as an adjuvant therapy to enhance neuronal connectivity following stroke. By combining electroencephalography (EEG) and tDCS, this study aims to investigate changes in network connectivity and cerebral plasticity, which are key factors in functional recovery after stroke. The objectives are to: 1) analyze how tDCS modulates neuronal activity, 2) evaluate persistent effects in follow-up assessments, and 3) predict patient outcomes. Studies on human subjects will be complemented by research in a mouse model of stroke to: 1) identify the molecular mechanisms underlying tDCS effects on functional recovery, 2) establish correlations among functional, molecular, and connectivity indices, and 3) assess the efficacy of biomimetic nanoparticles in targeting injured brain tissue to reduce inflammation, enhance neuronal plasticity, and support functional recovery.

Interventions

OTHERtDCS

Transcranial direct current stimulation

Sponsors

IRCCS San Raffaele Roma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Age 18-90 * First ischemic stroke occurring 3-30 days after onset * Residual upper limb function * Ability to provide informed consent and understand instructions

Exclusion criteria

* Severe spasticity (Ashworth \>2) * Presence of additional neurological diseases * Significant comorbidities * History of intracerebral hemorrhage * Severe neglect * Contraindications to tDCS

Design outcomes

Primary

MeasureTime frameDescription
Evaluate effects of tDCS in short-term follow-ups in terms of EEG Coherencefrom month 8 to month 12Analysis of Magnitude Squared Coherence to evaluate short-term tDCS effects
Evaluate persistent effect of tDCS in long-term follow-ups of EEG CoherenceFrom month 15 to the end of projectAnalysis of Magnitude Squared Coherence evaluate long-term tDCS effects
Evaluate effects of tDCS in short-term follow-ups in terms of EEG Connectivityfrom month 8 to month 12Analysis of EEG Connectivity to evaluate short-term tDCS effects
Evaluate persistent effect of tDCS in long-term follow-ups of EEG ConnectivityFrom month 15 to the end of projectAnalysis of EEG Connectivity to evaluate long-term tDCS effects
Predict patients' outcomethrough study completion, an average of 1 yearUse of AI to predict the outcome of the patient

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026